FDA Alert
FDA Alert
06/01/2023

Jessica Ganga

Jessica Ganga
The FDA has approved the first orally administered treatment for the gut infection—clostridioides difficile.
06/01/2023
Disease Prevention
Disease Prevention
12/13/2022
Following three studies that examined its safety and efficacy, the FDA approves the first fecal microbiota product to prevent recurring Clostridioides difficle infection in patients.
12/13/2022
Urology
Urology
11/15/2019
The new antibacterial drug was approved after it was proven safe and effective in a study of 448 patients with complicated UTIs.
11/15/2019
Lung Infections
Lung Infections
08/15/2019
After a clinical trial showed positive results in 89% of participants, a new drug regimen was approved by the FDA for highly drug-resistant forms of pulmonary tuberculosis.
08/15/2019
FDA
FDA
07/17/2019
A new 3-drug antibacterial drug injection containing an FDA-approved antibiotic and a new β-lactamase inhibitor has been approved.
07/17/2019
Emerging Infections
Emerging Infections
09/19/2018
In an FDA statement, Scott Gotlieb, MD, discusses the pathogen added to the list of foodborne pathogens to routinely test for, why it was added, and the FDA’s ongoing efforts to screen domestic and imported...
09/19/2018
Treatment
Treatment
08/29/2018
The FDA has approved a new injectable fluorocycline antibiotic for the treatment of complicated intraabdominal infections.
08/29/2018
Treatment
Treatment
02/02/2018
The FDA has expanded the indication for a drug formerly approved for the treatment of patients with complicated intra-abdominal infections and complicated urinary tract infections.
02/02/2018
FDA
FDA
09/18/2017
The US Food and Drug Administration has approved a new option for the treatment of bacterial vaginosis in adult women.
09/18/2017
FDA
FDA
08/30/2017
The US Food and Drug Administration has approved a new treatment option for adult patients with complicated urinary tract infections, including pyelonephritis.
08/30/2017